LON:SALV - SalvaRx Group Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 4.50
+0.30 (1.20%)

This chart shows the closing price for SALV by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New SalvaRx Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SALV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SALV

Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for SalvaRx Group in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 4.50.

This chart shows the closing price for SALV for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in SalvaRx Group. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/4/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/4/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/31/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/28/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/28/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/11/2018Northland SecuritiesReiterated RatingCorporate
10/23/2018Northland SecuritiesReiterated RatingCorporate
9/27/2018Northland SecuritiesReiterated RatingCorporate
8/14/2018Northland SecuritiesDowngradeCorporate
3/9/2018Northland SecuritiesReiterated RatingBuyGBX 180
10/23/2017Northland SecuritiesReiterated RatingBuyGBX 180
4/5/2017Northland SecuritiesReiterated RatingBuyGBX 149
3/20/2017Northland SecuritiesReiterated RatingBuyGBX 149
2/28/2017Northland SecuritiesReiterated RatingBuyGBX 149
9/13/2016Northland SecuritiesReiterated RatingCorporate
8/22/2016Northland SecuritiesReiterated RatingBuyGBX 149
(Data available from 7/28/2016 forward)

SalvaRx Group

SalvaRx Group plc discovers and develops immune-oncology drugs. The company is based in Ramsey, Isle of Man.
Read More

Today's Range

Now: GBX 4.50
Low: 4.50
High: 7.90

50 Day Range

MA: GBX 4.50
Low: 4.50
High: 4.50

52 Week Range

Now: GBX 4.50
Low: 4.50
High: 7.90

Volume

50,758 shs

Average Volume

50,758 shs

Market Capitalization

£1.65 million

P/E Ratio

0.03

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of SalvaRx Group?

The following Wall Street analysts have issued reports on SalvaRx Group in the last year:
View the latest analyst ratings for SALV.

What is the current price target for SalvaRx Group?

0 Wall Street analysts have set twelve-month price targets for SalvaRx Group in the last year. has the lowest price target set, forecasting a price of £100,000 for SalvaRx Group in the next year.
View the latest price targets for SALV.

What is the current consensus analyst rating for SalvaRx Group?

SalvaRx Group currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for SALV.

What other companies compete with SalvaRx Group?

How do I contact SalvaRx Group's investor relations team?

SalvaRx Group's physical mailing address is Commerce House, 1 Bowring Road, RAMSEY, RAMSAY, IM8 2LQ, Isle of Man. The company's listed phone number is +44-1624-811611. The official website for SalvaRx Group is www.salvarx.io.